June 2026
The RNA editing for neurodegenerative diseases market is growing as advanced RNA technologies target conditions like Alzheimer’s and Parkinson’s.
September 2026
The RNA editing therapies market expands with clinical progress in precision therapeutics, rare disease solutions, and gene-based medicine.
September 2026
The global RNA editing market size was valued at USD 16.91 billion in 2026 and is expected to surpass around USD 27.79 billion by 2035, growing at a CAGR of 5.71% from 2026 to 2035.
July 2026
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
September 2026
The genetic editing for ASCVD market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The global alternative fuel vehicle market is projected to hit around USD 1,314.44 billion by 2035 from USD 505.03 billion in 2026 with a CAGR of 11.59%
September 2026
The global complementary and alternative medicine market size is valued at USD 241.70 billion in 2026 and is expected to hit around USD 1,412.89 billion by 2035 with a CAGR of 22.00%.
September 2026
The internal combustion engine market demand is expected to surge around 5,58,977.43 thousand units by 2035 from 2,37,045.81 thousand units in 2025 with a CAGR of 8.96%.
September 2026
The global genome editing market size is evaluated at USD 12.76 billion in 2026 and is projected to worth around USD 48.19 billion by 2035 with a CAGR of 16.01%.
September 2026
The global alternative protein market size was surpassed at USD 19.50 billion in 2026 and is predicted to attain around USD 38.91 billion by 2035 with a CAGR of 8%.
September 2026
The miRNA tools market reached USD 642.07 billion in 2026, with key miRNA tools companies including thermos fisher scientific, agilent technologies, Qiagen, illumine inc, Bio-Rad laboratories inc.
September 2026
The global alternative accommodation market size is projected to hit around USD 1,043.15 billion by 2035 from USD 272.07 billion in 2026, with a solid CAGR of 16.15%.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
September 2026
The global clinical AI model governance market size was evaluated at USD 2.58 billion in 2026 and is predicted to hit around USD 55.00 billion by 2035, growing at a CAGR of 40.46%.
September 2026
The global external ventricular drain market size was valued at USD 8.23 billion in 2026 and is projected to hit around USD 13.47 billion by 2035 with a CAGR of 5.66%.
September 2026
The U.S. targeted DNA RNA sequencing market size is accounted to hit around USD 27.72 billion by 2035 increasing from USD 5.73 billion in 2026, with a CAGR of 19.17%.
September 2026
The enterprise governance, risk and compliance solutions market size stood at USD 18.24 billion in 2026, with major SAP SE, Oracle Corporation, IBM Corporation, MetricStream Inc., RSA Security LLC companies including enterprise governance, risk and compliance solutions market.
September 2026
The AI ethics and governance solutions market reached USD 2.44billion in 2026, featuring leading AI ethics and governance solutions market companies such as IBM Corporation, Microsoft Corporation, Accenture Plc, Google LLC (Alphabet Inc.), SAS Institute Inc.
September 2026
The AI in healthcare governance and safety market size stood at USD 2.96 billion in 2026, with major AI in healthcare governance and safety market companies including IBM, Microsoft, Oracle, Google Cloud.
July 2026
The dairy alternatives market size was exhibited at USD 34.59billion in 2025 and is predicted to hit around USD 102.74 billion by 2035 with a solid CAGR of 11.50%.
July 2026
The phase Ib gene editing trials market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.66 billion in 2026, with a CAGR of 11.14%.
April 2026
The global AI governance market size is estimated to hit around USD 5,883.90 million by 2035, increasing from USD 419.45 million in 2026, with a CAGR of 34.27%.
July 2025
The RNA therapy clinical trials market size was valued at USD 3.05 billion in 2026 and is expected to hit around USD 4.11 billion by 2034 with a CAGR of 3.84%.
September 2026
The bioengineering market was valued at USD 347.04 billion in 2026, with leading companies including Roche Holding AG, Agilent Technologies, Johnson & Johnson.
August 2025
The global long-acting injectables (LAIs) market size was evaluated at USD 16.94 billion in 2024 and is predicted to hit around USD 57.26 billion by 2034, growing at a CAGR of 12.95%.
July 2025
The global nucleic acid therapeutics market size reached USD 5.77 billion in 2024 and is projected to surpass around USD 17.02 billion by 2034 with a solid CAGR of 11.42%.
July 2025
The pregnancy medication market size was estimated at USD 42.24 billion in 2024 and is expected to hit around USD 144.93 billion by 2034, growing at a CAGR of 14.70%.
July 2025
The tire pyrolysis oil market size was evaluated at USD 357.99 million in 2024 and is expected to surge around USD 595.34 million by 2034 with a CAGR of 5.22%.
September 2026
The autonomous data platform market reached USD 2.60 billion in 2026, featuring leading autonomous data platform market companies such as MapR Technologies, Inc., Alteryx Inc., Ataccama Corporation, Cloudera, Inc..